Results for “”

Entry Author Date Location
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy 08/07/20 National
Biogen to Pay Denali $1B to Partner on Parkinson’s Drug & Other Neuro Meds 08/06/20 San Francisco
IgGenix Grabs $10M to Advance Antibody Treatments for Allergies 08/05/20 San Francisco
As Patients Pivot to Telehealth, Teladoc & Livongo Plan $18.5B Tie-Up 08/05/20 New York
CymaBay PBC Drug Hits Phase 3 Goals With Signs of Side Effect Advantage 08/04/20 San Francisco
Kymera Therapeutics Unveils IPO Pitch for Protein Degradation 07/31/20 Boston
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Novartis Pays $75M to Get Hands on Sangamo’s Zinc Fingers for Drug R&D 07/30/20 San Francisco
Roche Pays $120M for Rights to UCB’s Tau-Targeting Alzheimer’s Drug 07/29/20 Europe
Nura Bio Debuts With $73M and Plan to Develop “Neuroprotective” Drugs 07/29/20 San Francisco
Gilead Gets Another CAR-T Approval, This Time for Mantle Cell Lymphoma 07/24/20 San Francisco
Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More 07/24/20 National
FDA Lifts CymaBay Drug Hold, Tests to Resume in Rare Liver Disease PBC 07/23/20 San Francisco
Seer Raises $55M to Commercialize Tools to Analyze the Proteome 07/22/20 San Francisco
Olema Adds $54M to Start Human Tests of Breast Cancer Drug Candidate 07/22/20 San Francisco
Gilead Sciences Splashes Out $300M for Tizona Stake & Option to Acquire 07/21/20 San Francisco
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Last Chance for Xconomy Awards Nominations – Deadline is Friday, July 17 07/15/20 Boston
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact 07/14/20 Boston
Amgen Doubles Down on BeiGene Collaboration, Investing $421M More 07/13/20 San Francisco
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments 07/13/20 National
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing 07/02/20 San Francisco
Annexon Adds On $100M to Advance Antibodies to Treat Neurodegeneration 07/01/20 San Francisco
Ultragenyx Pharma Wins FDA’s First Drug Nod for Rare Metabolic Disorder 06/30/20 San Francisco
FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data 06/29/20 New York
CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy 06/25/20 Philadelphia
Gilead Grabs Option to Acquire Pionyr & Its Clinic-Bound Immunotherapies 06/23/20 San Francisco
Invitae Makes a Precision Oncology Push With $886M Deal for ArcherDx 06/22/20 San Francisco
Page 1 of 104 next page »